Skip NavigationSkip to Content
Return Return to Search Results

The SARS-CoV S glycoprotein

  1. Author:
    Xiao, X.
    Dimitrov, D. S.

  2. Author Address

    NCI, Prot Interact Grp, LECB, CCR,NIH, Frederick, MD 21702 USA Dimitrov, DS, NCI, Prot Interact Grp, LECB, CCR,NIH, Bldg 469,Room 105, Frederick, MD 21702 USA
    1. Year: 2004
    2. Date: OCT
  2. Journal: Cellular and Molecular Life Sciences
    1. 61
    2. 19-20
    3. Pages: 2428-2430
  4. Type of Article: Article
  1. Abstract:

    The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike ( S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. Recent rapid advances in our knowledge of the structure and function of this protein have lead to the development of a number of candidate vaccine immunogens and SARS-CoV entry inhibitors

    See More

  1. Keywords:

External Sources

  1. View record in Web of Science®
  2. WOS: 000224888600002

Library Notes

  1. No notes added.
NCI at FrederickClose Button

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel